HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1.

Abstract
Today, the major problem in organ transplantation is not acute graft rejection but chronic graft deterioration. In addition to alloantigen-specific events, alloantigen independent factors like donor age, previous diseases, consequences of brain death, and perioperative events of ischemia/reperfusion injury have a major impact on long-term graft function. The induction of the stress protein heme oxygenase-1 (HO-1) protects cells from injury and apoptosis. Here, we tested the protective effects of HO-1 induction in a clinically relevant kidney transplant model. Induction of HO-1 expression following cobalt-protoporphyrin (CoPP) treatment in organ donors prolonged graft survival and long-term function remarkably following extended periods of ischemia. Positive effects were observed with both optimal and marginal grafts from old donor animals. Structural changes characteristic for chronic rejection, as well as graft infiltration by monocytes/macrophages and CD8+ T cells, were substantially reduced following HO-1 induction. Up-regulation of HO-1 expression before organ transplantation was also associated with reduced levels for tumor necrosis factor (TNF)-alpha mRNA, increased levels for interferon (IFN)-gamma, and bcl-x, and insignificant differences for CD25, interleukin (IL)-2, IL-4, IL-6, and IL-10 mRNA levels. The significant improvement of long-term graft function following induction of HO-1 expression in donor organs suggests that this strategy may be a novel clinical treatment option with particular relevance for transplantation of marginal organs.
AuthorsStefan G Tullius, Melina Nieminen-Kelhä, Roland Buelow, Anja Reutzel-Selke, Paulo N Martins, Johann Pratschke, Ulrike Bachmann, Manfred Lehmann, Daniel Southard, Suhasani Iyer, Georg Schmidbauer, Birgit Sawitzki, Petra Reinke, Peter Neuhaus, Hans-Dieter Volk
JournalTransplantation (Transplantation) Vol. 74 Issue 5 Pg. 591-8 (Sep 15 2002) ISSN: 0041-1337 [Print] United States
PMID12352873 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukins
  • Protoporphyrins
  • RNA, Messenger
  • Receptors, Interleukin-2
  • Cobalt
  • Heme Oxygenase (Decyclizing)
  • Heme Oxygenase-1
Topics
  • Animals
  • Cobalt (pharmacology)
  • Enzyme Induction (drug effects)
  • Gene Expression Regulation, Enzymologic
  • Heme Oxygenase (Decyclizing) (biosynthesis, genetics)
  • Heme Oxygenase-1
  • Interleukins (genetics)
  • Kidney Transplantation (immunology, pathology, physiology)
  • Male
  • Protoporphyrins (pharmacology)
  • RNA, Messenger (genetics)
  • Rats
  • Rats, Inbred F344
  • Rats, Inbred Lew
  • Receptors, Interleukin-2 (genetics)
  • Reperfusion Injury (prevention & control)
  • T-Lymphocytes (pathology)
  • Transcription, Genetic
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: